Prescribing intelligence for hormone replacement therapies (HRTs)
GPrX Data captures all UK community prescribing data for hormone replacement therapies (HRT). Our online tool provides easy access to business intelligence for sales and marketing representatives.
Overall, HRT prescribing is increasing. Unopposed oestrogen has the greatest market share of HRT, representing aproximately 45% of prescription items.
Select an RxIndex for the adjunctive progestogen, continuous combined, gonadomimetic, sequential combined and unopposed oestrogen markets.
More on HRT from GPrX
Reports relevant to the HRT market coming soon!